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Objective: To investigate the correlation between the podocyte injury indexes in urine
such as nephrin, desmin, P-cadherin, podocin, podocalyxin and CD2-associated protein
(CD2AP) and the kidney function in patients with acute kidney injury (AKI).
Methods: A total of 120 severe postsurgical patients treated in the Intensive Care Unit of
our hospital from May 2012 to October 2015 were selected and divided into AKI group
(n = 38) and non-AKI group (n = 82) according to the diagnostic criteria of AKI. After
admission to the Intensive Care Unit for 24 h, their blood samples were collected to detect
the contents of serum creatinine (Scr), serum urea (SUrea), b2-microglobulin (b2-MG)
and cystatin C (Cys-C), and urine samples were collected to detect the contents of kidney
injury molecule-1 (KIM-1), liver-type fatty acid binding protein (L-FABP), Netrin-1,
nephrin, desmin, P-cadherin, podocin, podocalyxin and CD2AP.
Results: For patients in AKI group, the contents of Scr, SUrea, b2-MG and Cys-C in
their blood samples and the contents of KIM-1, L-FABP, Netrin-1, nephrin, desmin, P-
cadherin, podocin, podocalyxin and CD2AP in their urine samples were both signiﬁcantly
higher than those in non-AKI group. The contents of nephrin, desmin, P-cadherin,
podocin, podocalyxin and CD2AP in urine samples and contents of Scr, SUrea, b2-MG,
Cys-C and neutrophil gelatinase associated lipocalin in blood samples were positively
correlated with the contents of KIM-1, L-FABP, and Netrin-1 in urine.
Conclusions: Contents of podocyte injury molecules in urine of patients with acute
kidney injury such as nephrin, desmin, P-cadherin, podocin, podocalyxin and CD2AP
raised remarkably and the changes were consistent with the changes of kidney function
indexes in the blood and urine samples.1. Introduction
Acute kidney injury (AKI) is a common severe clinical disease
with a high fatality rate caused by multiple factors which involves
various subjects. The common primary pathogenesis causingAKI
are severe infection, massive haemorrhage, major surgery or
major trauma[1,2]. According to the RIFLE, the severity degree of
AKI can be divided into risk stage, injury stage and failure stage,
and the prognosis conditions can be divided into loss stage,terminal stage and kidney disease stage[3,4]. Although the
severity degree of AKI condition can be accurately conﬁrmed
and the prognosis can be estimated according to the RIFLE, the
diagnosis of the disease mainly depends on the contents of
serum creatinine (Scr) and serum urea (SUrea) and the changes
of urinary volume, which is of great difﬁculty for early
diagnosis[5]. In recent years, more and more clinical scholars
have realized that the vital factor for causing an extremely high
fatality rate of AKI is the lack of reliable markers for diagnosis[6].
Glomerular podocyte is a highly differentiated somatic cell.
Podocytes connect each other through transmembrane protein
and intermediate ﬁlament protein and then participate in the
formation of the selective ﬁltration barrier of glomerular capil-
lary wall. In the process of AKI, when the podocyte, the last
defense for glomerular ﬁltration barrier, is injured, the function
of glomerular ﬁltration could be destroyed along with the
presence of proteinuria[7–9]. Nephrin, desmin, P-cadherin,
podocin, podocalyxin and CD2-associated protein (CD2AP)
are important protein molecules connected podocytes. Podocyte
injury can result in the excretion of the above protein moleculesunder the CC BY-NC-ND license (http://
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demonstrated by detecting the contents of nephrin, desmin, P-
cadherin, podocin, podocalyxin and CD2AP in urine[10–12]. At
present, whether the podocyte injury is involved with the
pathophysiologic process of AKI and the relations between the
marker molecules of podocyte injury and the changes of
kidney function of AKI are not yet precisely reported. In the
following study, we analyzed the correlation between
podocyte injury and kidney function in patients with AKI.
2. Materials and methods
2.1. Study subjects
A total of 120 cases of severe postsurgical patients treated in
the Intensive Care Unit (ICU) of our hospital from May 2012 to
October 2015 were selected as study subjects after obtaining an
approval from the hospital ethics committee. They were divided
into AKI group (n = 38) and non-AKI group (n = 82) according to
the diagnostic standards recommended by the Kidney Disease
Improving Global Outcomes (2012). The selected standards were
as follow: (1) The kidney function deteriorated within 48 h, and
the increased absolute value of Scr had exceeded 26.4 mmol/L or
increased more than 50% compared with the basal value or the
urine volume was less than 0.5 mL/kg per hour, which lasted for
more than 6 h; (2) Clinical data were completed and the clinical
samples such as blood and urine samples were collected; (3) Pa-
tients with a history of chronic renal disease, kidney surgery and
any access to nephrotoxic drugs, incomplete laboratory data and
unsaved clinical samples were excluded.
2.2. Study methods
2.2.1. Methods for collecting clinical samples
After admission to ICU for 24 h, 5 mL of peripheral venous
blood of patients of the two groups was collected and left for
standing and blood was coagulated for 30 min at room tem-
perature. Then the samples were placed in the centrifugal ma-
chine and centrifuged at 12000 r/min for 20 min, and the serum
was separated, transferred into a clean EP tube (1.5 mL),
numbered and preserved in the refrigerator at −80 C. Five
milliliters of clean middle urine specimens of those patients were
collected simultaneously, transferred into clean EP tubes
(1.5 mL) and also numbered and then preserved in the refrig-
erator at −80 C, respectively.
2.2.2. Detection methods for clinical indexes
Fully automatic biochemical analyzer was used to detect Scr
and SUrea. ELISA was used to detect the contents of b2-
microglobulin (b2-MG) and cystatin C (Cys-C) in serum and
the contents of kidney injury molecule-1 (KIM-1), liver-type
fatty acid binding protein (L-FABP), Netrin-1, nephrin, des-
min, P-cadherin, podocin, podocalyxin and CD2AP in urine. All
the operation sequences were strictly carried out in accordance
with the instruction of test kits.
2.2.3. Statistical methods
Software SPSS version 19.0 was used for the input and
analysis of data. Measurement data were expressed bymean ± SD. And t-test was used for the analysis between two
groups. Enumeration data were expressed by frequency forms
and analyzed by Chi-square test. Correlation between two var-
iables was tested by the Pearson's correlation analysis. Differ-
ence was considered as statistically signiﬁcance when P < 0.05.
3. Results
3.1. General data of two groups' subjects
Out of the 38 patients in AKI group, 24 cases were males and
14 were females in AKI group with ages of (48.4 ± 7.2) years
and body mass index (BMI) of (23.12 ± 2.97) kg/m2. Among
them, there were 5 cases of hypertension (13.16%), 4 cases of
diabetes (10.53%) and 14 cases with smoking history (36.84%)
in this group, and the contents of triglyceride was (1.58 ± 0.19)
mmol/L and cholesterol was (4.09 ± 0.62) mmol/L. In non-AKI
group, there were 52 males and 30 females with age of
(49.1 ± 6.9) years and BMI of (23.06 ± 3.14) kg/m2. Among
them, there were eleven cases of hypertension (13.41%), 9 cases
of diabetes (10.98%) and 32 cases of smoking history (39.02%).
The contents of triglyceride and cholesterol were (1.61 ± 0.20)
mmol/L and (4.14 ± 0.67) mmol/L, respectively. According to
statistical analysis, the gender, age, BMI, case numbers of hy-
pertension, diabetes, smoking history and the contents of tri-
glyceride and cholesterol in AKI group had no signiﬁcant
differences with those in non-AKI group (P > 0.05).
3.2. Indexes of kidney function of two groups' subjects
The kidney function indexes of patients in AKI group such
as Scr, SUrea, b2-MG, Cys-C, KIM-1, L-FABP and Netrin-1
were analyzed as follow. Contents of Scr [(216.48 ± 32.57)
vs. (82.32 ± 10.14) mmol/L], SUrea [(18.85 ± 2.28) vs.
(7.14 ± 0.93) mmol/L], b2-MG [(5.82 ± 0.74) vs. (1.09 ± 0.14)
mg/mL] and Cys-C [(3.57 ± 0.41) vs. (1.15 ± 0.18) mg/mL] in blood
samples and contents of KIM-1 [(2.59 ± 0.41) vs. (1.14 ± 0.18) ng/
mL],L-FABP [(22.68±4.28) vs. (10.49±1.64) ng/mL] andNetrin-
1 [(8.59±1.05) vs. (3.62±0.49) pg/mL] inurine samples of patients
in AKI group were all signiﬁcantly higher than those of non-AKI
group. Differences of contents of Scr, SUrea, b2-MG and Cys-C
in blood samples and differences of contents of KIM-1, L-FABP
and Netrin-1 in urine samples in two groups were considered sta-
tistically signiﬁcant (P < 0.05).
3.3. Indexes of podocyte injury of two groups' subjects
The podocyte injury indexes of two groups' patients in urine
including nephrin, desmin, P-cadherin, podocin, podocalyxin and
CD2AP were analyzed. The contents of nephrin [(9.48 ± 1.17) vs.
(4.16 ± 0.67) ng/mL], desmin [(7.35 ± 0.87) vs. (3.24 ± 0.45)
ng/mL], P-cadherin [(204.52 ± 31.67) vs. (94.45 ± 11.37) pg/mL],
podocin [(15.27 ± 2.25) vs. (6.48 ± 0.93) ng/mL], podocalyxin
[(6.74 ± 0.85) vs. (3.42 ± 0.45) ng/mL] and CD2AP [(189.34 ±
22.62) vs. (67.86 ± 8.53) pg/mL] in urine of patients in AKI group
were all signiﬁcantly higher than those of non-AKI group. Differ-
ences of the contents of nephrin, desmin, P-cadherin, podocin,
podocalyxin and CD2AP in urine of two groups' patients were
considered statistically signiﬁcant (P < 0.05).
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The results of Pearson's correlation indicated that the contents
of nephrin, desmin, P-cadherin, podocin, podocalyxin and
CD2AP in urine samples and the contents of Scr, SUrea, b2-
MG, Cys-C and neutrophil gelatinase associated lipocalin
(NGAL) in blood samples were positively correlated with the
contents of KIM-1, L-FABP and Netrin-1 in urine.
4. Discussion
AKI is a common factor causing deaths for patients with
severe disease in clinic. Kidney hypoperfusion caused by the
decrease of cardiac output and the massive release of inﬂam-
matory mediators caused by severe infection are the key links
causing acute injury on kidney function, which can result in
injuries of glomerular ﬁltration function and acute tubular ne-
crosis. Creatinine and urea nitrogen are the metabolism
byproducts of proteins in body which mainly excrete through
kidney. AKI can affect the excretion of creatinine and urea ni-
trogen in blood circulation and result in an increase of the
contents of Scr and SUrea. Scr and SUrea are considered as the
markers for the diagnosis of AKI and the disease evaluation in
clinic. However, the excretion of Scr and SUrea can be regulated
by the compensation of kidney itself, and the increase of their
contents occurs few days or even few weeks after AKI, which is
disadvantage for the early diagnosis of the disease. b2-MG, Cys-
C and NGAL are moleculars of kidney function evaluation
which develop in recent years. Both b2-MG and Cys-C can be
ﬁltrated through glomerulus. The former one can be excreted in
urine, while the later can be reabsorbed and degraded in prox-
imal convoluted tubule. Function injury of glomerular ﬁltration
and low ﬁltration rate caused by AKI can affect the excretion of
b2-MG and Cys-C, which further results in the accumulation of
b2-MG and Cys-C in blood circulation[13–16]. By analyzing the
contents of the above moleculars in blood samples of patients
in two groups, we found that the contents of Scr, SUrea, b2-
MG, Cys-C and NGAL in blood samples of patients in AKI
group were signiﬁcantly higher than those of non-AKI group,
which indicated that the increase of the contents of Scr, SUrea,
b2-MG, Cys-C and NGAL in blood circulation were closely
related to kidney function injury in patients with AKI.
In the pathological process of AKI, kidney function injury
can cause not only the changes of the contents of the above
moleculars in blood circulation, but also the changes of contents
of various moleculars in urine. KIM-1, a kind of transmembrane
glycoprotein, has immune globulin and mucin structural domain
which participates in the regulation of intercellular adhesion and
growth and differentiation of cells. When AKI caused by
ischemia or intoxication occurs, proximal tubule epithelial cells
begin to dedifferentiate and then massively express KIM-1. With
the development of AKI and the complete glomerulus atrophy,
the renal tubular epithelial cells can barely express KIM-1.
Therefore, KIM-1 excreted in urine can be used to diagnose
the early injury of proximal convoluted tubule[17,18]. L-FABP is a
member of fatty acid binding proteins which can carry out b-
oxidation by the combination and transport of long chain fatty
acid. L-FABP mainly locates at epithelial cells of the proximal
tubules. The injury of proximal kidney tubules caused by AKI
can lead to the entry of L-FABP into urine and then theL-FABP will be excreted. Therefore, the content of L-FABP
in urine can reﬂect the injury of proximal kidney tubules[18–20].
Netrin-1 is a protective cytokine with anti-inﬂammatory ef-
fects. When AKI occurs, the compensatory expression of Netrin-
1 in proximal convoluted tubule raises[21]. By analyzing the
contents of the above moleculars in urine samples of patients
in the two groups, we found that the contents of KIM-1, L-
FABP and Netrin-1 in urine of patients in AKI group were
obviously higher than those of non-AKI group, which indicated
that the increase of the contents of KIM-1, L-FABP and Netrin-1
in urine was closely related to the kidney function injury in
patients with AKI.
Although the changes of the contents of moleculars
mentioned above in blood and urine samples can demonstrate
the kidney function of patients with AKI, it is difﬁcult to
conduct early diagnosis of AKI merely according to the detec-
tion of the above moleculars. Podocyte injury is a pathological
link related to AKI which is found in recent years[22,23].
Podocytes locate at the outermost layer of glomerular
basement membrane and is the ﬁnal link for the formation of
glomerular ﬁltrating barrier. The morphological change and
structural damage of podocytes can result in the occurrence of
proteinuria[24,25]. Nephrin, P-cadherin, podocin and CD2AP are
transmembrane proteins regulating the intercellular adhesion
and integrity of slit membrane. Nephrin and P-cadherin are
adhesion molecules which regulate intercellular adhesion and
are responsible for the integrity of slit membrane. Podocin and
CD2AP are involved with the composition of protein
complexes of slit membrane, which maintain the normal form
and complete structure of foot processes. Desmin and
podocalyxin are intermediate ﬁlament proteins of podocyte
cytoskeleton and the marker moleculars of podocyte injury as
well[26,27]. When AKI causes podocyte injury, the protein
markers in podocytes and the transmembrane proteins in cells
can be excreted in urine. We analyzed the indexes of podocyte
injury in urine from two groups' patients and the results
indicated that the contents of nephrin, desmin, P-cadherin,
podocin, podocalyxin and CD2AP in urine of patients in AKI
group were remarkably higher than those of non-AKI group,
and the contents of Scr, SUrea, b2-MG, Cys-C and NGAL in
blood samples were positively correlated with the contents of
KIM-1, L-FABP and Netrin-1 in urine. All indicated that
podocyte injury is a vital link of kidney function injury for pa-
tients with AKI, and the detection of podocyte injury indexes in
urine can be the evaluation reference for AKI kidney function.
In conclusion, the contents of podocyte injure moleculars
including nephrin, desmin, P-cadherin, podocin, podocalyxin
and CD2AP in urine of patients with AKI signiﬁcantly increase
and the changes are consistent with the changes of kidney
function indexes in blood samples and urine samples.
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